ASCO '12: Colon Cancer Drugs Good (Roche) and Very Bad (Keryx Pharma)
ASCO '12: Colon Cancer Drugs Good (Roche) and Very Bad (Keryx Pharma) The Street
View ArticleFDA OKs screening test for colon cancer drug
FDA OKs screening test for colon cancer drug Yahoo/AP
View ArticleSpectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong...
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter Seeking Alpha
View ArticleSpectrum Pharma: Fusilev Drug Sales Smash Record in June
Spectrum Pharma: Fusilev Drug Sales Smash Record in June TheStreet.com
View ArticleFDA approves Sanofi/Regeneron colon cancer drug
FDA approves Sanofi/Regeneron colon cancer drug Reuters
View ArticleSpectrum Pharma Slashes Fusilev Price to Woo Doctors
Spectrum Pharma Slashes Fusilev Price to Woo Doctors TheStreet.com
View ArticleSanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection
Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection NY Times, NY
View ArticleAvastin Shows No Benefit for Earlier Colon Cancer: Study
Avastin Shows No Benefit for Earlier Colon Cancer: Study Medine Plus
View ArticleAmgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta In...
Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta In Patients With Colorectal Cancer Yahoo/PR Newswire
View ArticleSpectrum Pharma Implodes On Colossal Fusilev Sales Warning
Spectrum Pharma Implodes On Colossal Fusilev Sales Warning TheStreet.com
View ArticleNot Exactly What Investors Were Looking For
Not Exactly What Investors Were Looking For Motley Fool
View ArticleBristol-Myers Sues Genentech Over ‘Cabilly’ Patents
Bristol-Myers Sues Genentech Over ‘Cabilly’ Patents Bloomberg
View ArticleErbitux Tops Roche’s Avastin for Colon Cancer Survival
Erbitux Tops Roche’s Avastin for Colon Cancer Survival Bloomberg
View ArticleMerck KGaA's Drug Tops Roche's Avastin for Colon Cancer
Merck KGaA's Drug Tops Roche's Avastin for Colon Cancer Bloomberg
View ArticleAveo says lead drug unlikely to succeed in colon cancer study
Aveo says lead drug unlikely to succeed in colon cancer study Yahoo/Reuters
View ArticleAveo, Astellas end pact to develop cancer drug Tivozanib
Aveo, Astellas end pact to develop cancer drug Tivozanib Yahoo/Reuters
View ArticleFDA advisers back Exact Sciences colon cancer test
FDA advisers back Exact Sciences colon cancer test Yahoo/AP
View ArticleVNRX: Clinical Data Looks Promising For Colon Cancer Opportunity
VNRX: Clinical Data Looks Promising For Colon Cancer Opportunity Yahoo/Zacks.com
View ArticleAmgen gets expanded approval for colon cancer drug
Amgen gets expanded approval for colon cancer drug Yahoo/AP
View ArticleAmgen Highlights Phase 2 Results Of Vectibix Versus bevacizumab In...
Amgen Highlights Phase 2 Results Of Vectibix Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer Yahoo/PR NewsWire
View Article
